Vincerx Pharma to dissolve; estimates $0.04-$0.08 per share distribution to stockholders

Vincerx Pharma, Inc.

License agreement with Bayer terminated June 25, 2025; all IP rights reverted to Bayer.
All directors except acting CEO Raquel Izumi resigned effective June 30, 2025 due to pending dissolution.
Special meeting on July 16, 2025 to approve dissolution; estimated distribution range $0.04-$0.08 per share.
Delays in approval will reduce or eliminate distributions; board unanimously recommends FOR vote.
Stock now trades on OTC Pink under ticker VINC.

item 1.02item 5.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.